Latest Search
Quote
| Back Zoom + Zoom - | ||||
|
<Research>M Stanley: BUD APAC (01876.HK) Quarterly Results Weak, in Line; Rating Kept at Overweight
Recommend 4 Positive 6 Negative 5 |
||||
|
||||
|
BUD APAC (01876.HK) announced that its 4Q25 revenue was US$1.073 billion (organic revenue down 4.2% YoY), compared to the market consensus of US$1.08 billion and Morgan Stanley's expectation of US$1.07 billion, according to Morgan Stanley's research report. Adjusted EBITDA was US$167 million (organic revenue down 24.7% YoY), below the expectations of the market/ broker of US$183 million/ US$202 million. Adjusted net loss amounted to US$12 million. During the period, the Group's sales in the China market fell by 11.4%, and volume decreased by 3.9% (decline narrowed, with stabilized market share), with the organic average selling price down 7.7% YoY, mainly due to higher investment in trade channels and in-home/emerging channels. Therefore, the broker rated BUD APAC at Overweight, with a target price of $9. AASTOCKS Financial News Website: www.aastocks.com |
||||
Copied to Clipboard
 |
||||
